4//SEC Filing
BRADLEY PHARMACEUTICALS INC 4
Accession 0000864268-07-000006
CIK 0000864268operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 2:08 PM ET
Size
10.3 KB
Accession
0000864268-07-000006
Insider Transaction Report
Form 4
BRADLEY PHARMACEUTICALS INCNYSE: BDY
GLASSMAN BRADLEY
Senior VP - Sales & Marketing
Transactions
- Purchase
Common Stock
2007-05-07$20.36/sh+178.044$3,625→ 16,527.044 total(indirect: By 401(k))
Holdings
- 100,000
Stock Options (Right to buy)
Exercise: $13.41From: 2006-11-22Exp: 2015-11-21→ Common Stock (100,000 underlying) - 3,359(indirect: By 401(k))
Common Stock
- 20,880(indirect: By Trust)
Class B Common Stock
- 15,620(indirect: By Trust)
Common Stock
- 74,494
Common Stock
- 30,000
Stock Options (Right to buy)
Exercise: $7.05From: 2002-07-09Exp: 2011-07-08→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]April 2007 purchase of 178.044 shares at $20.36 through 401(k) plan.
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000864268
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 2:08 PM ET
- Size
- 10.3 KB